533P Real-world evidence on safety and effectiveness study of ribociclib plus hormonal therapy in HR+/HER2– advanced breast cancer in the middle east: Interim results from the REALEESA study.
Saved in:
| Title: | 533P Real-world evidence on safety and effectiveness study of ribociclib plus hormonal therapy in HR+/HER2– advanced breast cancer in the middle east: Interim results from the REALEESA study. |
|---|---|
| Authors: | Abdel-Razeq, H.1 (AUTHOR), Alsayed, A.2 (AUTHOR), Dawoud, E.3 (AUTHOR), Al Kharusi, S.S.4 (AUTHOR), Hammad Tirmazy, S.5 (AUTHOR), Ahmed, E.6 (AUTHOR), Alhawari, L.7 (AUTHOR), Kasseb, M.8 (AUTHOR), Soliman, W.9 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS426-S426. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
